|
NOTE
4 – EARNINGS PER SHARE
Basic
earnings per share are computed based on the weighted average number of shares of common stock outstanding during the period. Diluted
earnings per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common
shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options
and stock awards.
The
components of basic and diluted earnings per share were as follows:
SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE
| |
|
For the three months ended
March 31, 2022
|
|
|
For the nine months ended
March 31, 2022
|
|
| |
|
Net Loss |
|
|
Shares |
|
|
Per Share |
|
|
Net Income |
|
|
Shares |
|
|
Per Share |
|
| Basic income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) available to common shareholders |
|
$ |
(278,470 |
) |
|
|
11,249,606 |
|
|
$ |
(0.02 |
) |
|
$ |
1,316,284 |
|
|
|
11,249,449 |
|
|
$ |
0.12 |
|
| Effect of dilutive securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share grants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted income (loss) per share |
|
$ |
(278,470 |
) |
|
|
11,249,606 |
|
|
$ |
(0.02 |
) |
|
$ |
1,316,284 |
|
|
|
11,249,449 |
|
|
$ |
0.12 |
|
| |
|
For the three months ended
March 31, 2021
|
|
|
For the nine months ended
March 31, 2021
|
|
| |
|
Net Loss |
|
|
Shares |
|
|
Per Share |
|
|
Net Loss |
|
|
Shares |
|
|
Per Share |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss available to common shareholders |
|
$ |
(623,231 |
) |
|
|
11,343,406 |
|
|
$ |
(0.05 |
) |
|
$ |
(147,781 |
) |
|
|
11,571,878 |
|
|
$ |
(0.01 |
) |
| Effect of dilutive securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share grants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(623,231 |
) |
|
|
11,343,406 |
|
|
$ |
(0.05 |
) |
|
$ |
(147,781 |
) |
|
|
11,571,878 |
|
|
$ |
(0.01 |
) |
For
the three month ended March 31, 2022, 5,000 share grants were excluded from the shares used to calculate diluted earnings per share as
their inclusion would have been anti-dilutive.
For
the three and nine months ended March 31, 2021, 30,699 share grants were excluded from the shares used to calculate diluted earnings
per share as their inclusion would have been anti-dilutive.
|